ABNB enters its June 5 earnings window carrying a contradictory message: analysts lifted targets across the board after the last print, but insiders have been selling into every uptick — and short interest has risen 12% over the past month.
The insider story is the most interesting thread this week. Co-founders and directors have been consistently trimming. Joseph Gebbia sold roughly 54,000 shares across multiple tranches on May 18 alone, collecting over $7.5 million. CFO Ellie Mertz sold nearly 7,000 shares on May 19. Co-founder Nathan Blecharczyk followed with further sales on May 19 and May 20. None of these are catastrophic individually — insiders at founder-heavy companies routinely monetise — but the cluster arriving three weeks before an earnings date is worth noting. The 90-day net position across all insiders is a net buy of roughly 288,000 shares, so the picture is mixed rather than decisively negative.
Short positioning has drifted meaningfully higher over the month. Short interest climbed from around 14.4 million shares in late April to 16.4 million, pushing SI as a percentage of free float to 3.9%. That's not a crowded trade by any measure, but the direction of travel is clear. Borrow remains cheap at 0.46% annualised and availability is extremely loose — shares outstanding for loan are running at nearly 8,000% of current short interest — meaning there is no friction at all for new shorts entering the trade. The put/call ratio at 1.06 is marginally below its 20-day average of 1.08 and roughly in the middle of its 52-week range, so options are neither flashing alarm nor complacency. The lending market tells a story of low-cost bearish positioning, not a squeeze setup.
The Street's reaction to the May print was constructive but split. After May 8 results, JP Morgan's Doug Anmuth raised his target from $130 to $140 while maintaining Neutral — a small move that signals relief rather than conviction. The more bullish camp — Citigroup, Wells Fargo, Benchmark, RBC — lifted targets more aggressively into the $160-$181 range, and all held positive ratings. RBC's Brad Erickson reiterated Outperform at $173 as recently as May 21. Barclays took a more cautious line, nudging its Equal-Weight target from $122 to $125, essentially marking it at current levels. The consensus remains Hold, with 18 Hold ratings against just 3 Outperforms, and the mean price target sits well above the current $132.68 print — implying the bulk of the Street sees upside but won't commit to Buy. The P/E at 24x has compressed by about 2.7 points over the past month, and EV/EBITDA has slipped half a point to 13.5x, so valuation is modestly cheaper than it was in April. The forward EPS growth rank in the 98th percentile is the standout factor score — the earnings-trajectory argument for bulls remains intact.
Peer divergence adds texture. BKNG gained 5.3% on the week and EXPE rose 3.7%, both outpacing ABNB's 1.2% gain. VAC surged 9.6%. The online travel complex broadly had a strong week. ABNB's relative underperformance — despite the analyst target lifts — is consistent with a stock where the near-term setup is messier than peers: the founder selling, the creeping short interest, and a stock that is down 7% over the past month even as the sector rallied.
The combination here is cautious rather than alarming. The lending market is too loose for any squeeze narrative. The analyst target lifts are real but stale by three weeks. What changes the picture either way is the June 5 print — after which the two most recent earnings releases saw the stock fall 2.4% on day one and decline further over the subsequent five sessions. The question is whether summer booking trends can deliver enough of a positive surprise to pull the stock back toward the $160+ targets the bulls are carrying.
See the live data behind this article on ORTEX.
Open ABNB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
